CryoTherapeutics

About:

CryoTherapeutics is focusing on the development, demonstration of clinical benefit & commercialization of a proprietary cryotherapy system.

Website: http://www.cryotherapeutics.com

Top Investors: HTGF | High-Tech Gruenderfonds, KfW, Meusinvest (Noshaq), GED Ventures Portugal, Creathor Ventures

Description:

CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.

Total Funding Amount:

28.7M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Potsdam, Brandenburg, Germany

Founded Date:

2009-01-01

Contact Email:

info(AT)cryotherapeutics.com

Founders:

Randy Werneth

Number of Employees:

11-50

Last Funding Date:

2024-04-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai